Medical Weight Loss for Southfield, Michigan Residents

Southfield, Michigan residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Southfield through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for Southfield residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your Michigan telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why Southfield Residents Choose New Hope Weight Loss

For Southfield patients who want a doctor genuinely involved, this is the right fit. Compounded semaglutide and tirzepatide are powerful tools, but they are not for everyone, and Dr. Anjmun Sharma treats them that way. She looks at your labs, your medications, and your goals before anything is prescribed, then keeps adjusting as your body responds. These medications are not FDA-approved and results vary, which is exactly why physician oversight matters this much.

Southfield is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Southfield address.

You do not need a clinic on your street in Southfield to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Michigan by secure telehealth. We care for patients throughout downtown Southfield and the northern Detroit metro area of Oakland County. We bill the $119 physician visit clearly and keep your medication billed separately, so the cost is transparent before anything ships to Michigan.

You can start this week from anywhere in Michigan, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. For patients across Southfield, compounded semaglutide starts at $166 per month, with a 90-day program available for $499, and the medication cost is kept separate from the $119 physician review. New Hope Weight Loss reaches patients all across Michigan, from the Lower Peninsula to the Upper, by telehealth from our Costa Mesa, California clinic, with no local office needed.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Southfield telehealth visits.

How Telehealth Works for Southfield

Here is what to expect, step by step, from anywhere in Southfield.

Step 1. Fill out a quick intake quiz about your weight, health history, and goals.

Step 2. Dr. Anjmun Sharma reviews your intake and meets you by secure video, usually within 48 hours, to decide whether compounded semaglutide or tirzepatide is right for you.

Step 3. If she prescribes, a state-licensed 503(a) pharmacy ships your medication to your Southfield address in cold-pack packaging.

Step 4. You keep going with video follow-ups, no office visit required, anywhere in .

Frequently Asked Questions, Southfield

Is New Hope Weight Loss available to Southfield without a local branch?

Yes, even though we have no branch in Southfield. Our one physical clinic is in Costa Mesa, California, and we reach Southfield, Michigan through telehealth. A secure video consult with Dr. Anjmun Sharma is where your medical history is reviewed and your fit for a compounded GLP-1 plan is confirmed.

From Southfield, can I avoid traveling for appointments?

You can skip travel entirely. The program is built around telehealth, so Southfield patients meet the doctor online, complete intake digitally, and stay connected by message. If approved, medication ships to your Southfield home in cold-pack packaging that maintains a safe temperature on the way.

What will Southfield patients spend on the program?

Expect $119 for the physician visit. Compounded semaglutide is offered from $166 per month or $499 for 90 days, and tirzepatide from $233 per month. The medication is billed separately. HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge for Southfield residents at all.

What areas of Southfield do you serve?

We serve patients from across Southfield by telehealth, including downtown Southfield and the northern Detroit metro area of Oakland County.

Are there hidden fees for Southfield patients?

No. Southfield patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Southfield Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Southfield, Michigan by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.